PCM
IMGN

Prelude Capital Management’s Immunogen Inc IMGN Stock Holding History

Prelude Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,100
Closed -$477K – 1585
2023
Q4 		$477K Buy
+16,100
New +$321K 0.03% 544

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prelude Capital Management's IMGN Position: Q1 2024 in Review

Prelude Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 157,856 shares — an estimated $4.68M sold.

Prelude Capital Management first reported a position in IMGN in Q2 2013 and held it in 18 quarters. The position peaked at $4.68M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Prelude Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Prelude Capital Management sold 157,856 Immunogen Inc shares in Q1 2024, an estimated $4.68M.
  • Prelude Capital Management first reported a position in Immunogen Inc in Q2 2013 and held it in 18 quarters.
  • Prelude Capital Management's Immunogen Inc position peaked at $4.68M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.